Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A phase III multi-centre randomised trial (ROSEL) has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for image-guided delivery, guidelines had to be developed in order to ensure uniformity in implementation of stereotactic radiotherapy in this multi-centre study. METHODS/DESIGN: A Quality Assurance Working Party was formed by radiation oncologists and clinical physicists from both academic as well as non-academic hospitals that had already implemented stereotactic radiotherapy for lung cancer. A literature survey was conducted and consensus meetings were held in which both the knowledge from the literature and clinical experience were pooled. In addition, a planning study was performed in 26 stage I patients, of which 22 were stage 1A, in order to develop and evaluate the planning guidelines. Plans were optimised according to parameters adopted from RTOG trials using both an algorithm with a simple homogeneity correction (Type A) and a more advanced algorithm (Type B). Dose conformity requirements were then formulated based on these results. CONCLUSION: Based on current literature and expert experience, guidelines were formulated for this phase III study of stereotactic radiotherapy versus surgery. These guidelines can serve to facilitate the design of future multi-centre clinical trials of stereotactic radiotherapy in other patient groups and aid a more uniform implementation of this technique outside clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
Postmus, P. E., Brambilla, E., Chansky, K., Crowley, J., Goldstraw, P., Patz, E. F., & Yokomise, H. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31811f4703 · Cited by 1,594
Timmerman, R., McGarry, R., Yiannoutsos, C., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5937 · Cited by 1,556
Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., 五味, 光., Niibe, Y., Karasawa, K., Hayakawa, K., Takai, Y., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318074de34 · Cited by 989
Onishi, H., Araki, T., Shirato, H., Nagata, Y., Hiraoka, M., Gomi, K., Yamashita, T., Niibe, Y., Karasawa, K., Hayakawa, K., et al. (2004) · Cancer · doi:10.1002/cncr.20539 · Cited by 891
Nagata, Y., Takayama, K., Matsuo, Y., Norihisa, Y., Mizowaki, T., Sakamoto, T., Sakamoto, M., Mitsumori, M., Shibuya, K., Araki, N., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.034 · Cited by 672
Potters, L., Kavanagh, B., Galvin, J. M., Hevezi, J. M., Janjan, N. A., Larson, D. A., Mehta, M. P., Ryu, S., Steinberg, M., Timmerman, R., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.042 · Cited by 664
Rami-Porta, R., Ball, D., Crowley, J., Giroux, D. J., Jett, J., Travis, W. D., Tsuboi, M., Vallières, E., & Goldstraw, P. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31807a2f81 · Cited by 637
Lagerwaard, F. J., Haasbeek, C. J. A., Smit, E. F., Slotman, B. J., & Senan, S. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.053 · Cited by 534
Self-citation4-dimensional computed tomography imaging and treatment planning
KEALL, P. (2004) · Seminars in Radiation Oncology · doi:10.1053/j.semradonc.2003.10.006 · Cited by 484
Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study
McGarry, R. C., Papiez, L., Williams, M., Whitford, T., & Timmerman, R. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.073 · Cited by 481
Geraghty, P. R., Kee, S. T., McFarlane, G., Razavi, M. K., Sze, D. Y., & Dake, M. D. (2003) · Radiology · doi:10.1148/radiol.2291020499 · Cited by 441
IASLC肺癌病期分類プロジェクト:肺癌TNM分類次版(第7版)におけるT desriptor修正の提案
Rami–Porta, R., Ball, D., Crowley, J., Giroux, D., Jett, J. R., Wd, T., Tsuboi, M., Vallières, E., & Goldstraw, P. G. (2007) · Journal of Thoracic Oncology · Cited by 381
El-Sherif, A., Gooding, W. E., Santos, R., Pettiford, B., Ferson, P. F., Fernando, H. C., Urda, S. J., Luketich, J. D., & Landreneau, R. J. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.02.029 · Cited by 354
Underberg, R. W. M., Lagerwaard, F. J., Slotman, B. J., Cuijpers, J. P., & Senan, S. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.045 · Cited by 315
Self-citationInternal‐external correlation investigations of respiratory induced motion of lung tumors
Ionascu, D., Jiang, S. B., Nishioka, S., Shirato, H., & Berbeco, R. I. (2007) · Medical Physics · doi:10.1118/1.2779941 · Cited by 209
Xiao, Y., Papiez, L., Paulus, R., Timmerman, R., Straube, W. L., Bosch, W. R., Michalski, J., & Galvin, J. M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.11.019 · Cited by 179
Four-Dimensional Treatment Planning for Stereotactic Body Radiotherapy
Gückenberger, M., Wilbert, J., Krieger, T., Richter, A., Baier, K., Meyer, J., & Flentje, M. P. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.074 · Cited by 152
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer
Timmerman, R. D., Park, C., & Kavanagh, B. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318074e4fa · Cited by 142
Survival after resection for primary lung cancer: a population based study of 3211 resected patients
Strand, T.-E. (2006) · Thorax · doi:10.1136/thx.2005.056481 · Cited by 142
Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration
Dieleman, E. M. T., Senan, S., Vincent, A. D., Lagerwaard, F. J., Slotman, B. J., & de Koste, J. R. V. S. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.09.054 · Cited by 107
Self-citationStereotactic body radiotherapy for bilateral primary lung cancers: The Indiana University experience
Sinha, B., & McGarry, R. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.06.042 · Cited by 47
Cited by
Goldstraw, P., Ball, D., Jett, J. R., Le Chevalier, T., Lim, E., Nicholson, A. G., & Shepherd, F. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62101-0 · Cited by 711
Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., Gomi, K., Karasawa, K., Hayakawa, K., Niibe, Y., Takai, Y., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1751 · Cited by 619
Recurrence after surgery in patients with NSCLC.
Uramoto, H., & Tanaka, F. (2014) · PubMed · doi:10.3978/j.issn.2218-6751.2013.12.05 · Cited by 540
Palma, D., Visser, O., Lagerwaard, F. J., Belderbos, J., Slotman, B. J., & Senan, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0731 · Cited by 479
Self-citationSenthi, S., Lagerwaard, F. J., Haasbeek, C. J., Slotman, B. J., & Senan, S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70242-5 · Cited by 447
Self-citation
Metadata
- Authors
- Hurkmans, C. W., Cuijpers, J. P., Lagerwaard, F. J., Widder, J., van der Heide, U. A., Schuring, D., & Senan, S.
- Venue
- Radiation Oncology
- Published
- 2009-01-12
- Volume
- 4
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1748-717X (ISSN-L)
- OpenAlex
- W2140057952
- Cited by
- 287
- References
- 22
- FWCI
- 29.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.